 |
 |

Intracameral Tissue Plasminogen Activator in Neovascular Glaucoma
Mildred M. G. Olivier, MD;
Talya H. Kupin, MD;
Mark L. McDermott, MD;
Dong H. Shin, MD
Detroit, Mich
Arch Ophthalmol. 1993;111(5):586.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Recent reports have documented the efficacy of tissue plasminogen activator in promoting fistula reformation following trabeculectomy1,2 and relieving fibrin-induced pupillary block after retinal procedures.3 We present herein a case in which we successfully used intracameral tissue plasminogen activator in a diabetic patient with neovascular glaucoma who developed a severe anterior chamber fibrin reaction following trabeculectomy with adjunctive mitomycin C.
Report of a Case.
—A 40-year-old black woman with moderate background diabetic retinopathy underwent an uncomplicated cataract extraction using phacoemulsification with implantation of a posterior chamber intraocular lens in the right eye. The postoperative visual acuity was 20/20. Four months after surgery the patient presented with rubeosis iridis, a 5% hyphema, and counting fingers visual acuity. Immediate panretinal photocoagulation was performed.
The patient remained in stable condition until 10 months later when she presented with a Serratia marcescens corneal ulcer and hypopyon in the right eye for which she
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|